Howard Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Howard Capital Management's BMY Position: Q2 2026 in Review
Howard Capital Management increased its Bristol-Myers Squibb (BMY) stake by 26% in Q2 2026, buying an estimated $552K and bringing the position to 46,206 shares worth $2.66M. The position accounts for 0.03% of the portfolio, ranked #151.
Howard Capital Management first reported a position in BMY in Q2 2020 and has held it in 9 quarters since. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Howard Capital Management held 46,206 shares of Bristol-Myers Squibb worth $2.66M as of Q2 2026.
- Howard Capital Management bought 9,620 Bristol-Myers Squibb shares in Q2 2026, an estimated $552K.
- Bristol-Myers Squibb made up 0.03% of Howard Capital Management's portfolio in Q2 2026, its #151 holding.
- Howard Capital Management first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 9 quarters since.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.